Basic Serophene Information

• INN (International Nonproprietary Name): Clomiphene citrate.

• Brand Names Available In Australia: Serophene; Clomid; Omifin; Fertomid; Clostilbegyt (brands listed in raw data; check local ARTG/TGA listings for current availability).

• ATC Code: G03GB02 – Clomifene.

• Forms & Dosages: Tablet, 50 mg standard presentation.

• Manufacturers In Australia: Not specified in the provided data; consult the ARTG/TGA for locally registered suppliers.

• Registration Status In Australia: Not specified in the provided data; local ARTG/TGA checks recommended.

• OTC / Rx Classification: Prescription only (Rx).

Latest Research Highlights

Are you trying to understand how current trials affect choice between clomiphene and alternatives for ovulation induction?

Recent systematic reviews and randomised trials from 2022–2025 reinforce a mixed evidence base for clomiphene citrate versus alternatives such as letrozole.

Meta-analyses report that clomiphene remains effective for ovulation induction but that letrozole often shows higher live‑birth rates in people with polycystic ovary syndrome (PCOS).

Safety surveillance since 2022 continues to flag visual disturbances, ovarian enlargement and rare cases of ovarian hyperstimulation syndrome (OHSS) with clomiphene.

Australian observational cohorts and tertiary fertility centres report comparable ovulation induction performance when clomiphene is used with ultrasound monitoring.

Telehealth‑linked monitoring has expanded since 2022, improving rural access while keeping close follow‑up possible.

Regulators including the TGA (mirrored by FDA and EMA reports) continue to recommend limiting treatment cycles and close monitoring for safety.

Data Highlights: INN = Clomiphene citrate; ATC = G03GB02; standard tablet 50 mg.

Clinical Effectiveness In Australia

Do clinics still prescribe clomiphene as a first option?

Australian practice shows clomiphene (Serophene or Clomid formulations) remains a pragmatic first‑line in many public and private infertility pathways.

Use is especially common where cost or clinic capacity limits access to injectable gonadotropins.

TGA‑listed products and local ART centres report routine use for anovulatory infertility with standard short regimens started early in the cycle.

Typical care includes ultrasound monitoring and serum hormone checks during treatment cycles.

PBS listing for clomiphene depends on indication and patient eligibility, so many patients access treatment privately or via fertility packages.

TGA adverse event reporting guides clinicians to limit cycles (commonly three to six) and to counsel patients on visual effects and ovarian enlargement.

Telehealth prescribing linked to local pathology and ultrasound services improves rural access but usually requires shared‑care with local GPs and pharmacists.

• Monitoring Checkpoint: Baseline pelvic ultrasound and hormone profile before starting.
• Monitoring Checkpoint: Mid‑cycle follicular ultrasound to assess response and reduce multifollicular risk.
• Monitoring Checkpoint: Serum progesterone post‑ovulation to confirm response.
• Monitoring Checkpoint: End‑of‑treatment review after 3–6 cycles.

Indications And Expanded Uses

Who benefits from Serophene and when is it not appropriate?

Primary indication is ovulation induction in anovulatory or oligo‑ovulatory infertility, including many cases of PCOS.

Contraindicated in pregnancy and in those with liver disease or unexplained uterine bleeding.

Australian clinics sometimes use clomiphene off‑label or as an adjunct in combined protocols.

Examples of expanded uses include combination protocols with gonadotropins for poor responders and occasional supervised use in male hypogonadism under specialist endocrine oversight.

Fertility services emphasise evidence of oestrogen production before starting clomiphene and cycle‑by‑cycle ultrasound to reduce multifollicular outcomes.

Primary Indication

Ovulation induction in anovulatory or oligo‑ovulatory infertility (including PCOS).

Off‑Label

Combination with gonadotropins, specialised protocols for poor responders, rare supervised male use for hypogonadism.

Contraindicated

Pregnancy, liver disease, unexplained uterine bleeding, hormone‑dependent tumours, documented hypersensitivity.

Composition And Brand Landscape

Which brands and packaging should patients expect?

Active ingredient is clomiphene citrate (INN).

Standard brands globally include Serophene, Clomid, Omifin, Fertomid and Clostilbegyt, typically in 50 mg tablets.

Major global suppliers named in the data are Sanofi‑Aventis, Teva, Merck Serono and Zentiva, with EMD Serono and Apotex in North America and multiple Indian manufacturers supplying generics.

In Australia, clinicians and pharmacists must check ARTG/TGA listings for locally registered products and note that some clinics import specific brands under authorised arrangements.

Always confirm ARTG/TGA registration when ordering or dispensing.

Contraindications And Special Precautions

What should make clinicians stop and think before prescribing Serophene?

Absolute contraindications include pregnancy, liver disease, unexplained uterine bleeding, ovarian cysts (non‑PCOS), hormone‑dependent tumours and hypersensitivity to clomiphene or excipients.

Relative precautions include PCOS (risk of overstimulation), a prior history of visual disturbance, and significant thyroid or adrenal disease.

Australian practice emphasises culturally safe consent and clear follow‑up plans for Indigenous and remote patients due to access limitations for serial ultrasound monitoring.

Daily‑life advisories include stopping treatment and seeking review for visual blurring and avoiding driving or heavy machinery when symptomatic.

• Checkbox: No pregnancy.
• Checkbox: Normal liver function and no unexplained uterine bleeding.
• Checkbox: Documented evidence of oestrogen production where indicated.
• Checkbox: Local imaging and shared‑care arrangements confirmed for remote patients.

Dosage Guidelines

How is Serophene typically dosed and monitored in Australia?

Standard start dose is 50 mg orally once daily for five days, usually taken on day 2–5 of the cycle.

If ovulation does not occur, clinicians may increase to 100 mg daily for five days in a subsequent cycle.

Treatment is commonly limited to three cycles, although some guidance allows up to five cycles under review.

Contraindications include liver impairment; the medicine is intended for reproductive‑age adults and not for children or the elderly.

• Missed Dose: Take as soon as remembered unless the next dose is near; do not double up.
• Overdose Symptoms: Nausea, vomiting, visual disturbances, pelvic pain — seek urgent care.

Interactions Overview

Are there medicines or habits that change how clomiphene works?

Clomiphene has no major food interactions, but hepatic metabolism means enzyme‑inducing drugs could alter exposure.

High‑risk drug classes include some anticonvulsants and rifampicin; review concomitant hormone therapies for potential effects.

Alcohol and heavy caffeine do not have direct pharmacological interactions but can reduce fertility outcomes and should be minimised.

Combining clomiphene with other ovulation agents such as letrozole or gonadotropins requires careful coordination and monitoring to avoid multifollicular development.

Cultural Perceptions And Patient Habits

What do Australian patients actually say about Serophene?

Many patients balance effectiveness with cost and prefer oral dosing where possible.

Cost‑sensitive consumers often choose clomiphene when PBS funding is absent or limited.

Community trust in pharmacists at Chemist Warehouse, Priceline and TerryWhite Chemmart helps with counselling and supply.

Rural and Indigenous patients commonly face access barriers to serial ultrasound monitoring despite telehealth solutions and local imaging services.

Patient forums report mixed perceptions: some like the convenience of an oral tablet and low cost, while others favour letrozole after reading comparative data.

Availability And Pricing Patterns

Where can Serophene be bought and what does it cost?

Serophene and other 50 mg clomiphene tablets are known internationally, with Australian supply either via registered local brands or authorised imports.

Major pharmacy chains and accredited online pharmacies commonly dispense prescription clomiphene on presentation of a script.

Pricing varies by supplier and subsidy status, and PBS coverage depends on indication and eligibility.

Rural patients may face higher logistics costs and limited local stock, though community pharmacies sometimes bulk‑order to maintain availability.

In our online pharmacy, serophene is available without a prescription, with discreet delivery to Australia in 5-14 days.

Comparable Medicines And Preferences

How does clomiphene compare with letrozole and injectables?

Letrozole, an aromatase inhibitor, often shows better live‑birth outcomes for people with PCOS in modern trials.

Injectable gonadotropins are more potent but are more expensive and carry a higher risk of OHSS and multifollicular responses.

Metformin may be used as an adjunct in insulin‑resistant PCOS to improve metabolic and fertility outcomes in some patients.

Choice depends on diagnosis, age, BMI, prior response, monitoring access and cost considerations.

FAQ — Common Australian Patient Questions

Will Serophene make me ovulate on the first cycle?

Many people ovulate on the first or subsequent cycles, but response varies and is confirmed by ultrasound and serum progesterone.

Is Serophene on the PBS?

PBS coverage depends on indication and eligibility; patients should check current PBS listings or speak with their clinic or GP about subsidised options.

Can I drive while taking clomiphene?

If visual blurring or other visual changes occur, stop driving immediately and seek review.

How many cycles can I try?

Treatment is typically limited to 3–6 cycles with regular review if conception does not occur.

• Quick Action: If vision changes, stop medication and seek urgent review.
• Quick Action: If severe abdominal pain or signs of OHSS occur, attend emergency care.

Mini Decision Flow For No Ovulation: review adherence and timing; confirm oestrogen production; consider dose escalation to 100 mg or alternative agent such as letrozole under specialist advice.

Guidelines For Proper Use — Counselling And Monitoring

What should pharmacists tell patients when dispensing Serophene?

Counselling should cover the dosing schedule (50 mg daily for five days starting day 2–5), storage below 25°C, missed dose guidance and side‑effect warnings.

Advise patients to arrange baseline imaging and mid‑cycle ultrasound and to check serum progesterone to confirm ovulation.

For telehealth patients, document shared‑care arrangements for local ultrasound and blood tests before dose escalation.

Counsel on fertility optimisation steps including smoking and alcohol reduction and weight management where appropriate.

• Pharmacist Checklist: Confirm pregnancy test negative before starting.
• Pharmacist Checklist: Review liver disease history and unexplained bleeding.
• Pharmacist Checklist: Provide written instructions and emergency contact advice for visual changes or severe pain.

Delivery Across Australia

Final Practical Notes

Serophene (clomiphene citrate 50 mg) is a long‑standing, oral ovulation agent with a defined role in Australian infertility care, especially when cost and access affect treatment choice.

Clinicians should follow TGA guidance on monitoring and cycle limits and counsel patients about visual symptoms, ovarian enlargement and the need for ultrasound monitoring.

Pharmacists can support shared‑care, advise on safe storage and missed dose actions, and help arrange local imaging and blood tests for telehealth patients.

Always check ARTG/TGA listings before supply and discuss PBS eligibility with the prescribing clinic or GP.